AVI-4658

· Sarepta Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AVI-4658, covering 2015-11-09 to 2015-11-09. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy Study of AVI-4658 to Induce Dystrophin Expression in Selected Duchenne Muscular Dystrophy Patients [Phase 2]

See pricing